Celldex Therapeutics
CLDX
#4701
Rank
A$2.77 B
Marketcap
A$41.64
Share price
-1.82%
Change (1 day)
30.57%
Change (1 year)

Market capitalization of Celldex Therapeutics (CLDX)

Market cap: A$2.77 Billion

As of March 2026 Celldex Therapeutics has a market cap of A$2.77 Billion. This makes Celldex Therapeutics the world's 4701th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celldex Therapeutics from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026A$2.77 B5.82%
2025A$2.61 B-3.29%
2024A$2.70 B-14.93%
2023A$3.18 B3.2%
2022A$3.08 B23.86%
2021A$2.49 B176.01%
2020A$0.90 B1569.28%
2019A$54.05 M7.29%
2018A$50.38 M-89.81%
2017A$0.49 B-0.51%
2016A$0.49 B-76.59%
2015A$2.12 B6.32%
2014A$1.99 B-17.52%
2013A$2.42 B482.9%
2012A$0.41 B271.22%
2011A$0.11 B-13.9%
2010A$0.13 B-21.07%
2009A$0.16 B-7.07%
2008A$0.17 B317.77%
2007A$42.42 M-66.6%
2006A$0.12 B-33.33%
2005A$0.19 B-1.03%
2004A$0.19 B-19.28%
2003A$0.23 B96.25%
2002A$0.12 B-74.41%
2001A$0.47 B-32.4%
2000A$0.70 B288.58%
1999A$0.18 B48.84%
1998A$0.12 B22.62%
1997A$99.08 M143.35%
1996A$40.71 M

End of Day market cap according to different sources

On Mar 17th, 2026 the market cap of Celldex Therapeutics was reported to be:

A$2.77 Billion
by Nasdaq info icon info icon
A$2.77 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$219.25 B 7,811.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$273.45 B 9,766.75%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$150.43 B 5,327.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
A$8.61 M-99.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
A$60.61 B 2,087.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$0.20 B-92.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.59 B-78.49%๐Ÿ‡บ๐Ÿ‡ธ USA